Impact of bleeding after transcatheter aortic valve replacement in patients with chronic kidney disease

Shawn X Li1, Nilay K Patel1, Laura D Flannery1

  • 1Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Insights

Patients with chronic kidney disease (CKD) face increased bleeding risks after transcatheter aortic valve replacement (TAVR). This bleeding is linked to higher mortality, underscoring the need for careful management post-TAVR.

Area of Science:

  • Cardiology
  • Nephrology
  • Transcatheter Aortic Valve Replacement (TAVR)
  • Chronic Kidney Disease (CKD)

Background:

  • Patients with chronic kidney disease (CKD) exhibit elevated bleeding risks post-transcatheter aortic valve replacement (TAVR).
  • The persistence of bleeding risk beyond the immediate procedure and its impact on mortality in CKD patients undergoing TAVR remain unclear.
  • Understanding these risks is crucial for optimizing patient care and outcomes.

Purpose of the Study:

  • To investigate bleeding risks in patients with CKD undergoing TAVR.
  • To determine the association between post-TAVR bleeding and subsequent mortality in CKD patients.
  • To analyze antithrombotic therapy patterns in CKD patients post-TAVR.

Main Methods:

  • Retrospective review of TAVR patients at Massachusetts General Hospital (2008-2017).
  • CKD defined as estimated glomerular filtration rate < 60 mL/min/1.73 m².
  • Primary endpoints included bleeding, all-cause mortality, and ischemic stroke up to 1 year post-TAVR, analyzed using Cox regression.

Main Results:

  • 60.3% of analyzed patients had CKD. CKD patients showed higher 1-year bleeding rates (9.2% vs. 4.9%) and all-cause mortality (13.7% vs. 9.1%).
  • Post-TAVR bleeding was significantly associated with increased subsequent mortality (aHR = 2.65, p = .01).
  • No significant difference in stroke rates or antithrombotic strategies was observed between CKD and non-CKD groups.

Conclusions:

  • Chronic kidney disease (CKD) is independently associated with increased bleeding risk up to one year following transcatheter aortic valve replacement (TAVR).
  • Long-term bleeding events after TAVR in CKD patients are linked to a higher risk of subsequent mortality.
  • Current antithrombotic strategies do not appear to differ between CKD and non-CKD patients post-TAVR.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
810
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
205
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
720
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
580
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
409
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
454